植物素抗胰腺癌的作用机制

doi:10.3760/cma.j.issn.1673-422X.2014.12.016

摘要/Abstract

摘要： 胰腺癌是恶性程度很高的肿瘤，5年生存率低于5%。随着诊疗技术的进步，胰腺癌患者症状得到了极大的改善，但其预后仍不乐观。近年来，来自于自然界的抗肿瘤植物得到了广泛关注。大量的实验室研究和临床试验表明姜黄素、异硫氰酸盐类、辣椒辣素、儿茶素等植物相关产品同降低肿瘤发病率之间有密切的相关性。

关键词: 姜黄素, 异硫氰酸盐类, 辣椒辣素, 儿茶素, 胰腺肿瘤

Abstract: Pancreatic cancer remains a devastating disease with a 5year survival rate of less than 5%. Recent advances in diagnostic methods and therapeutic approaches have increased the possibility of improving the existing poorprognosis. Recently, compounds from naturalsources receive ample attention as anticancer agents. Overwhelming in vitro evidence and clinical trials suggest that curcuminn, isothiocyanate, capsaicin, catechin may reduce the incidence of cancer.

Key words: Curcumin, Isothiocyanate, Capsaicin, Catechin, Pancreatic neoplasms

党军强, 陈媛, 林文, 李长彬. 植物素抗胰腺癌的作用机制[J]. 国际肿瘤学杂志, 2014, 41(12): 930-933.

DANG Jun-Qiang, CHEN Yuan, LIN Wen, LI Chang-Bin. Mechanism of phytochemicals as anticancer agents in parcreatic carcinoma[J]. Journal of International Oncology, 2014, 41(12): 930-933.

参考文献

［1］ Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: areview of the epidemiological evidence［J］. Nutr Cancer, 1992, 18(1): 129. ［2］ Anand P, Sundaram C, Jhurani S, et al. Curcumin and cancer: an "oldage" disease with an "algeold" solution［J］. Cancer Lett, 2008, 267(1): 133164. ［3］ Li L, Aggarwal BB, Shishodia S, et al. Nuclear factor kappa B and I kappa B kinase are constitutively active in human pancreaticcells, and their downregulation by curcumin (diferuloylmethane) isassociated with the suppression of proliferation and the induction ofapoptosis ［J］. Cancer, 2004,101(10): 23512362. ［4］ Hidaka H, Ishiko T, Furuhashi T, et al. Curcumin inhibits interleukin 8production and enhances interleukin 8 receptor expression on the cellsurfaceimpact on human pancreatic carcinoma cell growth by autocrineregulation［J］. Cancer, 2002, 95(6): 12061214. ［5］ Jutooru I, Chadalapaka G, Lei P, et al. Inhibition of NF kappa B and pancreatic cancer cell and tumor growth by curcumin is dependent onspecificity protein downregulation［J］. J Biol Chem, 2010, 285(33): 2533225344. ［6］ Lin L, Hutzen B, Zuo M, et al. Novel STAT3 phosphorylationinhibitors exhibit potent growthsuppressive activity in pancreatic and breastcancer cells［J］. Cancer Res, 2010, 70 (6): 24452454. ［7］陈干涛, 白少华, 高志强. 姜黄素联合顺铂抗胰腺癌细胞增殖的效应［J］. 中国中西医结合消化杂志, 2008, 16(1): 2628. ［8］ Li Y, Revalde JL, Reid G, et al. Modulatory effects of curcumin on multidrug resistanceassociated protein 5 in pancreatic cancer cells［J］. Cancer Chemother Pharmacol, 2010, 10(7): 15151520. ［9］ BoraTatar G, DayangacErden D, Demir AS, et al. Molecular modifications on carboxylic acid derivatives as potenthistone deacetylase inhibitors: activity and docking studies［J］. Bioorg Med Chem, 2009, 17(14): 52195228. ［10］ Ali S, Ahmad A, Aboukameel A, et al. Increased Ras GTPase activity is regulated by miRNAs that can be attenuatedby CDF treatment in pancreatic cancer cells［J］. Cancer Lett, 2012, 319(2): 173181. ［11］ Kanai M, Yoshimura K, Asada M, et al. A phase Ⅰ/Ⅱ study of gemcitabinebased chemotherapyplus curcumin for patients with gemcitabineresistant pancreatic cancer ［J］.Cancer Chemother Pharmacol, 2011, 68(1):157164. ［12］ Sahu RP, Srivastava SK. The role of STAT3 in the induction of apoptosis inpancreatic cancer cells by benzyl isothiocyanate［J］. J Natl Cancer Inst, 2009, 101(3): 176193. ［13］ Xu Q, Briggs J, Park S, et al. Targeting Stat3 blocks both HIF1 and VEGF expression induced by multiple oncogenic growth signalingpathways ［J］. Oncogene, 2005, 24(36): 55525560. ［14］ Schlieman MG, Fahy BN, Ramsamooj R, et al. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer［J］. Br J Cancer, 2003, 89(11): 21102115. ［15］ Batra S, Sahu RP, Kandala PK, Srivastava SK. Benzyl isothiocyanatemediated inhibition of histone deacetylase leads to NFkappa B turnoff inhuman pancreatic carcinoma cells［J］. Mol Cancer Ther, 2010, 9(6):15961608. ［16］ Boreddy SR, Sahu RP, Srivastava SK. Benzyl isothiocyanate suppressespancreatic tumor angiogenesis and invasion by inhibiting HIFalpha/VEGF/RhoGTPases: pivotal role of STAT3［J］. PLoS One, 2011, 6(10): e25799. ［17］ Zhang R, Humphreys I, Sahu RP, et al. In vitro and in vivo induction of apoptosis by capsain in pancreaticcancer cells is mediated through ROS generation and mitochondrial death pathway［J］. Apoptosis, 2008, 13(12): 14651478．［18］ Bai H, Li H, Zhang W, et al. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia(PanIN) by capsaicin in LSLKrasG12D/Pdx1Cre mice［J］. Carcinogenesis, 2011, 32(11): 16891696. ［19］ Min JK, Han KY, Kim EC, et al. Capsaicin inhibits in vitro and in vivo angiogenesis［J］. Cancer Res, 2004, 64(2): 644647. ［20］ Zhang L, Pang E, Loo RR, et al. Concomitantinhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAFⅡ cells［J］. Proteomics, 2011, 11(24): 46384647. ［21］ Kostin SF, McDonald DE, McFadden DW. Inhibitory effects of epigallocatechin3gallate and pterostilbene on pancreatic cancer growth in vitro［J］. J Surg Res, 2012, 177(2): 255262. ［22］ Shankar S, Ganapathy S, Hingorani SR, et al. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer［J］. Fron Biosci, 2008, 13: 440452. ［23］ Thakur VS, Gupta K, Gupta S. Green tea polyphenols increase p53transcriptional activity and acetylation by suppressing classⅠhistonedeacetylases［J］. Int J Oncol, 2012, 41(1): 353361. ［24］ Tsang WP, Kwok TT. Epigallocatechin gallate upregulation of miR16 andinduction of apoptosis in human cancer cells［J］. J Nutr Biochem, 2010, 21(2): 140146.

[1]	张洁, 范玲, 李杰, 温华, 苏媛媛, 路宁, 张明鑫. 原发性胰腺淋巴瘤1例并文献复习[J]. 国际肿瘤学杂志, 2024, 51(5): 316-320.
[2]	魁国菊, 黄江宾, 张文华, 杨立民. 区域淋巴结大小对胰头腺癌术后复发的影响[J]. 国际肿瘤学杂志, 2023, 50(10): 608-613.
[3]	严志颖, 毛逸锋, 朱颖蔚, 徐克群. 癌相关成纤维细胞的异质性在靶向胰腺癌治疗中的角色[J]. 国际肿瘤学杂志, 2021, 48(5): 308-312.
[4]	中国医师协会放射肿瘤治疗医师分会. 胰腺癌立体定向放疗(放射外科)指南[J]. 国际肿瘤学杂志, 2021, 48(11): 643-648.
[5]	钟扬, 何苗, 刘志, 陈建宇, 张光年, 秦龙, 李婷, 李建水. 麦冬皂苷D联合沉默环氧合酶-2基因对人胰腺癌BxPC-3细胞增殖、迁移和侵袭的影响[J]. 国际肿瘤学杂志, 2021, 48(10): 583-590.
[6]	李珂珂, 孔盼盼, 易超, 王喜艳, 晏冬. 淋巴样增强因子-1在胰腺导管腺癌中的表达及对预后的影响[J]. 国际肿瘤学杂志, 2021, 48(10): 608-613.
[7]	陈晓旭, 于洋, 张天雪. 基于免疫相关lncRNA建立胰腺癌预后风险评估模型[J]. 国际肿瘤学杂志, 2020, 47(8): 472-479.
[8]	田春方, 沙丹. 锌指蛋白与消化系统肿瘤[J]. 国际肿瘤学杂志, 2020, 47(2): 115-118.
[9]	纪周新, 贺德. 微生物群与胰腺癌[J]. 国际肿瘤学杂志, 2020, 47(1): 46-50.
[10]	靳小倩,韩春,王澜. 胰腺实性假乳头状瘤变异型快速进展一例[J]. 国际肿瘤学杂志, 2019, 46(4): 255-256.
[11]	李庆贺, 刘慧纯, 张家耀, 李伟. miR-200b-3p下调VEGFA调控胰腺癌细胞增殖、侵袭、迁移和凋亡的分子机制研究#br#[J]. 国际肿瘤学杂志, 2019, 46(11): 649-656.
[12]	李智,许静凯,张博. 长非编码RNA在肿瘤中的作用机制[J]. 国际肿瘤学杂志, 2018, 45(4): 220-222.
[13]	凌晓斐，胥可，邵华，王翠娟. 姜黄素类似物EF24的抗肿瘤机制与应用 [J]. 国际肿瘤学杂志, 2018, 45(3): 172-175.
[14]	李志坚，贺德. 液体活检在胰腺癌中的研究进展[J]. 国际肿瘤学杂志, 2018, 45(3): 180-182.
[15]	梁碧玉，何伟明，何小艺，丁元林，于海兵. 糖尿病及降糖药物与胰腺癌[J]. 国际肿瘤学杂志, 2018, 45(3): 183-186.